prof. dr. ir. Kathleen Claes
- Work address
-
C. Heymanslaan 10, ingang 34 (MRB)
9000 Gent - Kathleen.Claes@UGent.be
- ORCID iD
-
https://orcid.org/0000-0003-0841-7372
Show
Sort by
-
Extreme clustering of type-1 NF1 deletion breakpoints co-locating with G-quadruplex forming sequences
-
- journalArticle
- open access
Correction: Expanding the clinical phenotype of individuals with a 3-bp in-frame deletion of the NF1 gene (c.2970_2972del): an update of genotype–phenotype correlation
-
- journalArticle
- open access
A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk
-
- journalArticle
- open access
Expanding the clinical phenotype of individuals with a 3-bp in-frame deletion of the NF1 gene (c.2970_2972del): an update of genotype–phenotype correlation
-
- journalArticle
- A1
- open access
BRCA1 and BRCA2 5′ noncoding region variants identified in breast cancer patients alter promoter activity and protein binding
-
- journalArticle
- open access
Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study
-
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations
-
Accurate detection and quantification of epigenetic and genetic second hits in BRCA1 and BRCA2-associated hereditary breast and ovarian cancer reveals multiple co-acting second hits
-
Thorough in silico and in vitro cDNA analysis of 21 putative BRCA1 and BRCA2 splice variants and a complex tandem duplication in BRCA2 allowing the identification of activated cryptic splice donor sites in BRCA2 exon 11
-
The BRCA1 c. 5096G > A p.Arg1699Gln (R1699Q) intermediate risk variant : breast and ovarian cancer risk estimation and recommendations for clinical management from the ENIGMA consortium